| pubmed-article:7773939 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7773939 | lifeskim:mentions | umls-concept:C0238122 | lld:lifeskim |
| pubmed-article:7773939 | lifeskim:mentions | umls-concept:C0069515 | lld:lifeskim |
| pubmed-article:7773939 | lifeskim:mentions | umls-concept:C0079419 | lld:lifeskim |
| pubmed-article:7773939 | lifeskim:mentions | umls-concept:C1704824 | lld:lifeskim |
| pubmed-article:7773939 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
| pubmed-article:7773939 | lifeskim:mentions | umls-concept:C2911684 | lld:lifeskim |
| pubmed-article:7773939 | lifeskim:mentions | umls-concept:C0185117 | lld:lifeskim |
| pubmed-article:7773939 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:7773939 | pubmed:dateCreated | 1995-7-7 | lld:pubmed |
| pubmed-article:7773939 | pubmed:abstractText | Carcinoma of the fallopian tube is a rare gynecologic malignancy. Its histologic appearance and patterns of spread are similar to those of epithelial ovarian cancer. Alterations in the gene products of c-erbB-2 (HER-2/neu) and p53 are found commonly in ovarian tumors and may have prognostic relevance. The authors sought to determine whether tubal cancers are biologically similar to ovarian cancer with respect to the expression of these two molecular markers. | lld:pubmed |
| pubmed-article:7773939 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7773939 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7773939 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:7773939 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7773939 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7773939 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7773939 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:7773939 | pubmed:issn | 0008-543X | lld:pubmed |
| pubmed-article:7773939 | pubmed:author | pubmed-author:PodratzK CKC | lld:pubmed |
| pubmed-article:7773939 | pubmed:author | pubmed-author:ChaS CSC | lld:pubmed |
| pubmed-article:7773939 | pubmed:author | pubmed-author:WieandH SHS | lld:pubmed |
| pubmed-article:7773939 | pubmed:author | pubmed-author:RocheP CPC | lld:pubmed |
| pubmed-article:7773939 | pubmed:author | pubmed-author:KeeneyG LGL | lld:pubmed |
| pubmed-article:7773939 | pubmed:author | pubmed-author:HartmannL CLC | lld:pubmed |
| pubmed-article:7773939 | pubmed:author | pubmed-author:LiaoD ZDZ | lld:pubmed |
| pubmed-article:7773939 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7773939 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:7773939 | pubmed:volume | 75 | lld:pubmed |
| pubmed-article:7773939 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7773939 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7773939 | pubmed:pagination | 2891-6 | lld:pubmed |
| pubmed-article:7773939 | pubmed:dateRevised | 2010-3-24 | lld:pubmed |
| pubmed-article:7773939 | pubmed:meshHeading | pubmed-meshheading:7773939-... | lld:pubmed |
| pubmed-article:7773939 | pubmed:meshHeading | pubmed-meshheading:7773939-... | lld:pubmed |
| pubmed-article:7773939 | pubmed:meshHeading | pubmed-meshheading:7773939-... | lld:pubmed |
| pubmed-article:7773939 | pubmed:meshHeading | pubmed-meshheading:7773939-... | lld:pubmed |
| pubmed-article:7773939 | pubmed:meshHeading | pubmed-meshheading:7773939-... | lld:pubmed |
| pubmed-article:7773939 | pubmed:meshHeading | pubmed-meshheading:7773939-... | lld:pubmed |
| pubmed-article:7773939 | pubmed:meshHeading | pubmed-meshheading:7773939-... | lld:pubmed |
| pubmed-article:7773939 | pubmed:meshHeading | pubmed-meshheading:7773939-... | lld:pubmed |
| pubmed-article:7773939 | pubmed:meshHeading | pubmed-meshheading:7773939-... | lld:pubmed |
| pubmed-article:7773939 | pubmed:meshHeading | pubmed-meshheading:7773939-... | lld:pubmed |
| pubmed-article:7773939 | pubmed:meshHeading | pubmed-meshheading:7773939-... | lld:pubmed |
| pubmed-article:7773939 | pubmed:meshHeading | pubmed-meshheading:7773939-... | lld:pubmed |
| pubmed-article:7773939 | pubmed:meshHeading | pubmed-meshheading:7773939-... | lld:pubmed |
| pubmed-article:7773939 | pubmed:meshHeading | pubmed-meshheading:7773939-... | lld:pubmed |
| pubmed-article:7773939 | pubmed:meshHeading | pubmed-meshheading:7773939-... | lld:pubmed |
| pubmed-article:7773939 | pubmed:year | 1995 | lld:pubmed |
| pubmed-article:7773939 | pubmed:articleTitle | c-erbB-2 and p53 expression in fallopian tube carcinoma. | lld:pubmed |
| pubmed-article:7773939 | pubmed:affiliation | Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA. | lld:pubmed |
| pubmed-article:7773939 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7773939 | lld:pubmed |
